RAS Mutation
Oncology·MeSH: Neoplasms
7 drugs in development·7 companies·6 clinical trials
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| tipifarnib | Kura Oncology, Inc. (KURA) |
Phase 1(4)
Preclinical(1)
| Drug | Company |
|---|---|
| KRAS program | Cogent Biosciences, Inc. (COGT) |
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| envometinib | Immuneering Corp (IMRX) |
Compare drugs
Frequently asked questions
How many drugs are in development for RAS Mutation?
BioSniper tracks 7 drugs in development for RAS Mutation across 7 companies.
How many clinical trials target RAS Mutation?
There are 6 clinical trials targeting RAS Mutation tracked by BioSniper.
Deep-dive into RAS Mutation
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis